PharmaBio Serv (PBSV)
(Delayed Data from OTC)
$0.74 USD
0.00 (0.00%)
Updated Apr 25, 2024 01:28 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for PharmaBio Serv Inc falls in the month of October .
All items in Millions except EPS data.
10/31/23 | 10/31/22 | 10/31/21 | 10/31/20 | 10/31/19 | |
---|---|---|---|---|---|
Sales | 17 | 19 | 20 | 22 | 20 |
Cost Of Goods | 12 | 15 | 15 | 15 | 13 |
Gross Profit | 5 | 5 | 5 | 7 | 6 |
Selling & Adminstrative & Depr. & Amort Expenses | 4 | 4 | 9 | 4 | 4 |
Income After Depreciation & Amortization | 1 | 1 | -4 | 2 | 2 |
Non-Operating Income | 1 | 0 | 2 | 0 | 1 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 2 | 1 | -2 | 2 | 2 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 1 | 1 | -2 | 2 | 2 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 1 | 1 | -2 | 2 | 2 |
Depreciation Footnote | 10/31/23 | 10/31/22 | 10/31/21 | 10/31/20 | 10/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1 | 1 | -4 | 2 | 2 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | 1 | 1 | -4 | 2 | 2 |
Earnings Per Share Data | 10/31/23 | 10/31/22 | 10/31/21 | 10/31/20 | 10/31/19 |
---|---|---|---|---|---|
Average Shares | 23.00 | 23.03 | 23.16 | 23.04 | 23.11 |
Diluted EPS Before Non-Recurring Items | 0.06 | 0.04 | -0.09 | 0.09 | 0.09 |
Diluted Net EPS (GAAP) | 0.06 | 0.04 | -0.09 | 0.09 | 0.09 |
Fiscal Year end for PharmaBio Serv Inc falls in the month of October .
All items in Millions except EPS data.
1/31/24 | 10/31/23 | 7/31/23 | 4/30/23 | 1/31/23 | |
---|---|---|---|---|---|
Sales | 2.38 | 3.60 | 4.58 | 4.56 | 4.24 |
Cost Of Goods | 1.84 | 2.67 | 3.03 | 3.22 | 3.00 |
Gross Profit | 0.54 | 0.93 | 1.55 | 1.35 | 1.24 |
SG&A, R&D, and Dept/Amort Expenses | 0.97 | 0.98 | 1.09 | 0.97 | 0.91 |
Income After SG&A, R&D, and Dept/Amort Expenses | -0.43 | -0.05 | 0.46 | 0.38 | 0.33 |
Non-Operating Income | 0.18 | 0.00 | 0.13 | 0.19 | 0.25 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -0.26 | -0.05 | 0.59 | 0.57 | 0.58 |
Income Taxes | 0.01 | 0.00 | 0.06 | 0.17 | 0.15 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -0.27 | -0.05 | 0.53 | 0.40 | 0.43 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -0.27 | -0.05 | 0.53 | 0.40 | 0.43 |
Earnings Per Share Data | 1/31/24 | 10/31/23 | 7/31/23 | 4/30/23 | 1/31/23 |
---|---|---|---|---|---|
Average Shares | 22.96 | 22.97 | 22.97 | 23.02 | 22.96 |
Diluted EPS Before Non-Recurring Items | -0.01 | 0.00 | 0.02 | 0.02 | 0.02 |
Diluted Net EPS (GAAP) | -0.01 | 0.00 | 0.02 | 0.02 | 0.02 |